• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jvirolPermissionsJournals.ASM.orgJournalJV ArticleJournal InfoAuthorsReviewers
J Virol. Mar 1991; 65(3): 1408–1413.
PMCID: PMC239919

Transformation of T-lymphocyte subsets by Marek's disease herpesvirus.

Abstract

Marek's disease herpesvirus (MDV)-transformed lymphoblastoid tumor cell lines were characterized for the presence of the surface markers. Monoclonal antibodies were used for CD3 (T-cell receptor [TCR] complex), TCR1, TCR2, and TCR3, CD4, CD8, and Ia antigen by indirect fluorescence staining followed by microscopic examination or flow cytometry. The lymphoblastoid cell lines were obtained from tumors from chickens infected with MDV (n = 44) or from local lesions induced by inoculation of allogeneic, MDV-infected chick kidney cells (n = 56). Lymphocytes were harvested from these lesions between 4 and 16 days postinoculation and cultured in vitro to establish cell lines. All cell lines expressed Ia antigen and CD3 and/or TCR and thus are activated T cells. Most of the cell lines developed from tumors were CD4+ CD8-; only one cell line was negative for both markers. Sixteen percent of the cell lines were TCR3+, while the remainder were TCR2+. The cell lines developed from local lesions were much more heterogeneous: 45% were CD4- CD8+, 34% were CD4- CD8-, and only 21% were CD4+ CD8-. The number of TCR3+ cell lines was larger than expected for the CD4- CD8+ and CD4- CD8- cell lines, as judged from the presence of these cells in the blood. These results indicate that several subsets of T lymphocytes can be transformed by MDV, depending on the pathogenesis of infection. Activation of T cells as a consequence of the normal pathogenesis or by allogeneic stimulation seem to be a first important step in the process of transformation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Akiyama Y, Kato S. Two cell lines from lymphomas of Marek's disease. Biken J. 1974 Sep;17(3):105–116. [PubMed]
  • Bresser J, Doering J, Gillespie D. Quick-blot: selective mRNA or DNA immobilization from whole cells. DNA. 1983;2(3):243–254. [PubMed]
  • Bucy RP, Chen CH, Cooper MD. Ontogeny of T cell receptors in the chicken thymus. J Immunol. 1990 Feb 15;144(4):1161–1168. [PubMed]
  • Bumstead JM, Payne LN. Production of an immune suppressor factor by Marek's disease lymphoblastoid cell lines. Vet Immunol Immunopathol. 1987 Sep;16(1-2):47–66. [PubMed]
  • Buscaglia C, Calnek BW, Schat KA. Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J Gen Virol. 1988 May;69(Pt 5):1067–1077. [PubMed]
  • Caballero A, Garrido A, Algarra I, Perez M, Garrido F. Generation of syngeneic anti-tumour double negative cells (CD4- CD8-), with cytotoxic activity against clones of different MHC class I expression. J Immunogenet. 1989 Aug-Oct;16(4-5):321–328. [PubMed]
  • Calnek BW. Influence of age at exposure on the pathogenesis of Marek's disease. J Natl Cancer Inst. 1973 Sep;51(3):929–939. [PubMed]
  • Calnek BW. Marek's disease--a model for herpesvirus oncology. Crit Rev Microbiol. 1986;12(4):293–320. [PubMed]
  • Calnek BW, Lucio B, Schat KA, Lillehoj HS. Pathogenesis of Marek's disease virus-induced local lesions. 1. Lesion characterization and cell line establishment. Avian Dis. 1989 Apr-Jun;33(2):291–302. [PubMed]
  • Calnek BW, Murthy KK, Schat KA. Establishment of Marek's disease lymphoblastoid cell lines from transplantable versus primary lymphomas. Int J Cancer. 1978 Jan 15;21(1):100–107. [PubMed]
  • Calnek BW, Schat KA, Ross LJ, Shek WR, Chen CL. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int J Cancer. 1984 Mar 15;33(3):389–398. [PubMed]
  • Calnek BW, Shek WR, Schat KA. Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines. Infect Immun. 1981 Nov;34(2):483–491. [PMC free article] [PubMed]
  • Chan MM, Chen CL, Ager LL, Cooper MD. Identification of the avian homologues of mammalian CD4 and CD8 antigens. J Immunol. 1988 Apr 1;140(7):2133–2138. [PubMed]
  • Chen CL, Ager LL, Gartland GL, Cooper MD. Identification of a T3/T cell receptor complex in chickens. J Exp Med. 1986 Jul 1;164(1):375–380. [PMC free article] [PubMed]
  • Chen CL, Bucy RP, Cooper MD. T cell differentiation in birds. Semin Immunol. 1990 Jan;2(1):79–86. [PubMed]
  • Chen CH, Chanh TC, Cooper MD. Chicken thymocyte-specific antigen identified by monoclonal antibodies: ontogeny, tissue distribution and biochemical characterization. Eur J Immunol. 1984 May;14(5):385–391. [PubMed]
  • Chen CL, Cihak J, Lösch U, Cooper MD. Differential expression of two T cell receptors, TcR1 and TcR2, on chicken lymphocytes. Eur J Immunol. 1988 Apr;18(4):539–543. [PubMed]
  • Chen CH, Sowder JT, Lahti JM, Cihak J, Lösch U, Cooper MD. TCR3: a third T-cell receptor in the chicken. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2351–2355. [PMC free article] [PubMed]
  • Ewert DL, Munchus MS, Chen CL, Cooper MD. Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants. J Immunol. 1984 May;132(5):2524–2530. [PubMed]
  • Fukuchi K, Sudo M, Lee YS, Tanaka A, Nonoyama M. Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol. 1984 Jul;51(1):102–109. [PMC free article] [PubMed]
  • Groh V, Fabbi M, Hochstenbach F, Maziarz RT, Strominger JL. Double-negative (CD4-CD8-) lymphocytes bearing T-cell receptor alpha and beta chains in normal human skin. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5059–5063. [PMC free article] [PubMed]
  • Guidos CJ, Weissman IL, Adkins B. Developmental potential of CD4-8- thymocytes. Peripheral progeny include mature CD4-8- T cells bearing alpha beta T cell receptor. J Immunol. 1989 Jun 1;142(11):3773–3780. [PubMed]
  • Ikuta K, Nakajima K, Naito M, Ann SH, Ueda S, Kato S, Hirai K. Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides. Int J Cancer. 1985 Feb 15;35(2):257–264. [PubMed]
  • Jakowski RM, Fredrickson TN, Chomiak TW, Luginbuhl RE. Hematopoietic destruction in Marek's disease. Avian Dis. 1970 May;14(2):374–385. [PubMed]
  • Lee LF, Liu X, Witter RL. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J Immunol. 1983 Feb;130(2):1003–1006. [PubMed]
  • Lillehoj HS, Lillehoj EP, Weinstock D, Schat KA. Functional and biochemical characterizations of avian T lymphocyte antigens identified by monoclonal antibodies. Eur J Immunol. 1988 Dec;18(12):2059–2065. [PubMed]
  • McClure SJ, Hein WR, Yamaguchi K, Dudler L, Beya MF, Miyasaka M. Ontogeny, morphology and tissue distribution of a unique subset of CD4-CD8- sheep T lymphocytes. Immunol Cell Biol. 1989 Aug;67(Pt 4):215–221. [PubMed]
  • Murthy KK, Calnek BW. Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens. J Natl Cancer Inst. 1978 Sep;61(3):849–854. [PubMed]
  • Nazerian K, Sharma JM. Detection of T-cell surface antigens in a Marek's disease lymphoblastoid cell line. J Natl Cancer Inst. 1975 Jan;54(1):277–279. [PubMed]
  • Powell PC, Payne LN, Frazier JA, Rennie M. T lymphoblastoid cell lines from Marek's disease lymphomas. Nature. 1974 Sep 6;251(5470):79–80. [PubMed]
  • Schat KA. Marek's disease: a model for protection against herpesvirus-induced tumours. Cancer Surv. 1987;6(1):1–37. [PubMed]
  • Schat KA, Buckmaster A, Ross LJ. Partial transcription map of Marek's disease herpesvirus in lytically infected cells and lymphoblastoid cell lines. Int J Cancer. 1989 Jul 15;44(1):101–109. [PubMed]
  • Schat KA, Calnek BW, Fabricant J, Abplanalp H. Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance. Poult Sci. 1981 Dec;60(12):2559–2566. [PubMed]
  • Schat KA, Chen CL, Shek WR, Calnek BW. Surface antigens on Marek's disease lymphoblastoid tumor cell lines. J Natl Cancer Inst. 1982 Sep;69(3):715–720. [PubMed]
  • Schierman LW, McBride RA. Effects of vaccination for Marek's disease on growth of a Marek's-virus-induced transplantable lymphoma in syngeneic and allogeneic chickens. Avian Dis. 1979 Jan-Mar;23(1):47–56. [PubMed]
  • Smith MW, Calnek BW. Effect of virus pathogenicity on antibody production in Marek's disease. Avian Dis. 1973 Oct-Dec;17(4):727–736. [PubMed]
  • Sowder JT, Chen CL, Ager LL, Chan MM, Cooper MD. A large subpopulation of avian T cells express a homologue of the mammalian T gamma/delta receptor. J Exp Med. 1988 Feb 1;167(2):315–322. [PMC free article] [PubMed]
  • Strominger JL, Fabbi M, Prendergast M, Maziarz RT, Burakoff SJ, Groh V. Novel subsets of human T cells (CD4+ CD8- TCR gamma delta and CD4- CD8- TCR alpha beta) and T-cell development. Int J Cancer Suppl. 1989;4:43–47. [PubMed]
  • Weinstock D, Schat KA. Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. Prog Clin Biol Res. 1987;238:253–263. [PubMed]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...